Alzheimer’s drugs may not work and could raise brain risks

A major Cochrane review has found that drugs designed to target amyloid beta proteins in the brain are unlikely to provide meaningful benefits for patients. At the same time, these treatments appear to increase the risk of brain swelling and bleeding.

Click here to view the original article.